JUVÉDERM®VOLUMA®XC is the One and Only Hyaluronic Acid Dermal Filler Indicated to Treat Cheeks, Chin, and Now Moderate to Severe Temple Hollowing1,2 ...

The FDA has approved Juvéderm Voluma XC for the improvement of moderate to severe temple hollowing in the temple region in patients aged great than 21 years.

JUVÉDERM VOLUMA™ XC will be available in fall 2013. For more information about the JUVÉDERM ® family of products, please visit www.juvederm.com. INDICATION ...

"The approval of JUVÉDERM ® VOLUMA ® XC to treat temple hollows further demonstrates Allergan Aesthetics commitment to innovation and addressing patient needs," said Carrie Strom, ...

JUVEDERM VOLUMA XC prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and JUVEDERM VOLUMA XCside effects.

JUVÉDERM ® VOLUMA ™ XC is the first and only filler to receive U.S. FDA approval for the augmentation of the chin region. 1 This approval marks the second indication for the product, which was ...

FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid-Face ...

Juvéderm Voluma XC was approved by the U.S. Food and Drug Administration in December as the first injectable filler to instantly add volume to the cheek area. Similar to other fillers like ...

Patients treated with Juvéderm Voluma XC to correct infraorbital hollows reported high satisfaction rates and experienced low rates of adverse events, according to a study.A retrospective ...

JUVÉDERM ® VOLUMA ® XC is the One and Only Hyaluronic Acid Dermal Filler Indicated to Treat Cheeks, Chin, and Now Moderate to Severe Temple Hollowing 1,2 Only Allergan Aesthetics, the Makers of BOTOX ...